Department of General Practice and Health Services Research, University Hospital Heidelberg, Heidelberg, Germany.
Eur J Gen Pract. 2021 Dec;27(1):228-234. doi: 10.1080/13814788.2021.1962280.
Growing prevalence of chronic diseases is a rising challenge for healthcare systems. The Primary Care Practice-Based Care Management (PraCMan) programme is a comprehensive disease management intervention in primary care in Germany aiming to improve medical care and to reduce potentially avoidable hospitalisations for chronically ill patients.
This study aimed to assess the effect of PraCMan on hospitalisation rate and related costs.
A retrospective propensity-score matched cohort study was performed. Reimbursement data related to patients treated in general practices between 1st July 2013 and 31st December 2017 were supplied by a statutory health insurance company (AOK Baden-Wuerttemberg, Germany) to compare hospitalisation rate and direct healthcare costs between patients participating in the PraCMan intervention and propensity-score matched controls following usual care. Outcomes were determined for the one-year-periods before and 12 months after beginning of participation in the intervention.
In total, 6148 patients participated in the PraCMan intervention during the observation period and were compared to a propensity-score matched control group of 6148 patients from a pool of 63,446 eligible patients. In the one-year period after the intervention, the per-patient hospitalisation rate was 8.3% lower in the intervention group compared to control ( = 0.0004). Per-patient hospitalisation costs were 9.4% lower in favour of the intervention group ( = 0.0002).
This study showed that the PraCMan intervention may be associated with a lower rate of hospital admissions and hospitalisation costs than usual care. Further studies may assess long-term effects of PraCMan and its efficacy in preventing known complications of chronic diseases.
慢性病患病率的不断上升给医疗保健系统带来了新的挑战。初级保健实践为基础的照护管理(PraCMan)项目是德国初级保健中的一项综合性疾病管理干预措施,旨在改善医疗服务,减少慢性病患者潜在的可避免住院治疗。
本研究旨在评估 PraCMan 对住院率和相关成本的影响。
采用回顾性倾向评分匹配队列研究。一家法定健康保险公司(德国巴登-符腾堡州 AOK)提供了与 2013 年 7 月 1 日至 2017 年 12 月 31 日期间在全科诊所接受治疗的患者相关的报销数据,以比较接受 PraCMan 干预和按照常规护理接受倾向评分匹配对照的患者的住院率和直接医疗保健成本。结果在干预开始前一年和 12 个月后进行了评估。
在观察期间,共有 6148 名患者参与了 PraCMan 干预,与从 63446 名合格患者中抽取的 6148 名患者的倾向评分匹配对照组进行了比较。在干预后的一年中,干预组的每位患者住院率比对照组低 8.3%( = 0.0004)。干预组每位患者的住院费用降低了 9.4%( = 0.0002)。
本研究表明,与常规护理相比,PraCMan 干预可能与较低的住院率和住院费用相关。进一步的研究可以评估 PraCMan 的长期效果及其预防慢性病已知并发症的疗效。